Abiraterone prostate cancer drug molecule

Abiraterone prostate cancer drug molecule

C001/3750 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.4MB

Downloadable file size: 485.8KB

Price image Pricing

Please login to use the price calculator


Caption: Abiraterone. Molecular model of the drug abiraterone (C24.H31.N.O), which is being tested for use in the treatment of prostate cancer. Atoms are colour-coded spheres (carbon: light blue, nitrogen: dark blue, hydrogen: yellow, oxygen: red). The prostate is a gland beneath the bladder in men which produces a fluid that forms part of the semen. Elevated blood levels of testosterone may increase the risk of prostate cancer. Abiraterone blocks the production of testosterone by inhibiting an enzyme involved in its formation. This leads to the death of the cancerous cells.

Release details: Model release not required. Property release not required.

Keywords: 1, abiraterone, anti-cancer, atom, atoms, ball and stick, ball-and-stick, biochemical, biochemistry, biological, biology, block, blocking, cancer, chemical, chemistry, compound, compounds, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, drug, drugs, enzyme inhibitor, healthcare, inhibitor, inhibitory, medical, medication, medicine, molecular, molecular model, molecule, oncology, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prostate cancer, single, structural, structure, testosterone, testosterone blocker, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.